Manjula Pasumarthy's most recent trade in Divi's Laboratories Ltd. was a Disposal of 2,396 Equity Shares done at an average price of Rs. 3897.5 . Disclosure was reported to the exchange on Dec. 28, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Manjula Pasumarthy in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Manjula Pasumarthy | Employees Immediate Relative | Disposal | 28 Dec 2023 | 2,396 | 0 (0%) | 0.00% | 3897.5 | 9,338,298 | 27 Dec 2023 28 Dec 2023 |
Insider Trading | Equity Shares | Market Sale |
| Divi's Laboratories | Manjula Pasumarthy | Immediate Relative | Acquisition | 25 Feb 2022 | 200 | 2,396 (0%) | 0.00% | 3980 | 796,000 | 24 Feb 2022 24 Feb 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Divi's Laboratories | Manjula Pasumarthy | Immediate Relative | Acquisition | 29 Dec 2021 | 555 | 2,196 (0%) | 0.00% | 4502.0 | 2,498,637 | 09 Dec 2021 28 Dec 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Divi's Laboratories | Manjula Pasumarthy | Designated Person | Acquisition | 09 Dec 2021 | 240 | 1,641 (0%) | 0.00% | 4708.7 | 1,130,083 | 18 Nov 2021 07 Dec 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Divi's Laboratories | Manjula Pasumarthy | Immediate Relative | Acquisition | 20 Mar 2021 | 1,000 | 1,401 (0%) | 0.00% | 3330.1 | 3,330,091 | 17 Mar 2021 19 Mar 2021 |
Insider Trading | Equity Shares | Market Purchase |